Community Health Network — $345M Stark Law Settlement

What happened

Indianapolis-based Community Health Network (CHN) agreed to pay $345 million to resolve allegations that it violated the False Claims Act by knowingly submitting Medicare claims for services referred by physicians whose compensation arrangements violated the Stark Law. At announcement, this was the largest Stark Law FCA settlement in U.S. Department of Justice history — nearly triple the previous record ($115 million, Adventist Health, 2018).

The conduct began in 2008 and 2009, when CHN senior management initiated a strategy to recruit specialists into employment specifically to capture their "downstream referrals." The government alleged that CHN paid the recruited physicians salaries substantially higher than what they had earned in private practice — in some cases, double the prior compensation. The specialties at issue included cardiology, cardiothoracic surgery, vascular surgery, neurosurgery, and breast surgery: the highest- margin referral generators in a hospital system.

On top of those above-market base salaries, CHN allegedly paid "incentive compensation" bonuses tied to the volume or value of physician referrals — a direct violation of the Stark Law's prohibition on volume- or value-based compensation under the employed-physician exceptions.

The valuation-firm pattern is the case's heart

CHN did engage outside valuation firms. The government's complaint named two: Katz, Sapper & Miller (Indianapolis) and SullivanCotter (Chicago). On paper, this should have been the structural safeguard the Stark Law contemplates. In practice, the case turned on three things CHN allegedly did with the FMV process:

• Knowingly provided false compensation figures. The government alleged that CHN gave the valuation firms inputs it knew misrepresented the proposed compensation, so the firms would render favorable FMV opinions. The FMV opinion was real; the inputs used to generate it were not.
• Ignored the warnings that came back anyway. Even working from the manipulated inputs, the firms raised concerns. Katz Sapper & Miller concluded the compensation was "staggering" and "high compared to productivity in all specialties and primary care." SullivanCotter said the salaries were above fair market value and needed to be below the 75th percentile of national benchmark data. CHN proceeded anyway.
• Used the favorable opinion as paperwork cover. The complaint alleged CHN treated the FMV opinion as a compliance shield rather than a substantive judgment — a defensive document to point at rather than a constraint on the underlying arrangement.

The case originated as a qui tam action filed in July 2014 by Thomas Fischer, a former CHN executive. The U.S. Attorney's Office for the Southern District of Indiana intervened. CHN publicly characterized the government's efforts as "meritless" and a "waste of resources" through 2023, then settled in December of that year.

Beyond the $345 million payment, CHN entered into a five-year Corporate Integrity Agreement (CIA) with HHS-OIG — the same operational structure later applied to Independent Health (2024) and other recent settlements. A subsequent December 2024 settlement added $145.7 million in related claims, bringing total federal recoveries to approximately $490 million.

Why this matters — for compliance officers

Three things compliance officers at hospitals and health systems should hold onto from this case:

1. An FMV opinion is not a compliance shield. It is a substantive constraint. Every prior assumption about FMV opinions as "we hired a firm, we have the paperwork, we're covered" died with the CHN settlement. The case stands for the proposition that the FMV process is only protective when the inputs are accurate and the warnings are heeded. Manipulated inputs produce manipulated opinions; ignored warnings produce documented disregard. Both are recoverable by the government.

2. Volume-or-value bonuses on employed physicians are strict-liability traps. The Stark Law's employed- physician exceptions require that compensation not be based on the volume or value of referrals. "Productivity bonuses" that are actually referral-revenue bonuses are structurally the same conduct as the CHN case. Compliance officers should audit their organization's bonus formulas for every employed-physician arrangement and confirm the formula does not encode referral volume even indirectly.

3. The 15-year conduct window matters. CHN's alleged scheme began in 2008-2009. The qui tam was filed in 2014. The settlement landed in 2023. Stark Law exposure compounds over time and does not become safer with age. Every year an arrangement persists with unresolved FMV or safe-harbor gaps is another year of potential FCA damages stacking. The compliance posture that says "we'd have heard by now if it were a problem" is the posture that produced this settlement.

What ArrowISE learns from this case

This is a Direct-relevance case. The fact pattern at CHN sits at the center of ArrowISE's design intent — physician arrangement compliance under the Stark Law, with fair market value tracking, safe-harbor element validation, and pattern matching against documented enforcement profiles. Three of the five Defensibility Index dimensions would have surfaced the structural problems at CHN before the qui tam was filed in 2014; one specifically catches the valuation- firm manipulation pattern at the case's heart.

Schena-Shield™ pattern rules informed by this case:

Across the three Medicare Advantage cases in this library (Kaiser, Independent Health, Seoul Medical Group), the structural lesson was about documentation asymmetry. Community Health Network sharpens that lesson into the Stark Law domain ArrowISE is built for: an FMV opinion is the paperwork; the underlying compensation is the conduct, and the two must match in substance, not just in form.

The numbers